Entropy Technologies LP Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Entropy Technologies LP purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 38,817 shares of the company’s stock, valued at approximately $901,000.

Other institutional investors have also recently made changes to their positions in the company. UMB Bank n.a. boosted its stake in Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after buying an additional 750 shares during the period. GAMMA Investing LLC boosted its position in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after acquiring an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. grew its holdings in shares of Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares in the last quarter. International Assets Investment Management LLC increased its position in shares of Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after purchasing an additional 2,757 shares during the last quarter. Finally, Quarry LP raised its stake in Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after purchasing an additional 2,628 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Analysts Set New Price Targets

OPCH has been the topic of a number of research analyst reports. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and increased their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Truist Financial reduced their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $26.00 to $33.00 in a report on Monday, January 13th. JPMorgan Chase & Co. raised their price objective on Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $32.25.

Option Care Health Stock Performance

Shares of OPCH stock opened at $31.35 on Tuesday. The company has a market capitalization of $5.34 billion, a P/E ratio of 26.34, a PEG ratio of 2.19 and a beta of 1.35. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a 50 day moving average price of $26.04 and a two-hundred day moving average price of $27.87.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.